| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Novel Hypothesis: Certain KIR/Cognate Ligand Containing Genotypes Differ in Frequency Among Patients With Myeloma and Have an Effect on Age of Disease Onset
|
Beksac, Meral
|
|
|
23 |
5 |
p. 394-400.e1
|
article
|
| 2 |
A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia
|
Vydra, Jan
|
|
|
23 |
5 |
p. e232-e239
|
article
|
| 3 |
Association of Minimal Residual Disease Negativity Rates With Progression Free Survival in Frontline Therapy Trials for Newly Diagnosed Multiple Myeloma: A Meta-analysis
|
Ficek, Joseph
|
|
|
23 |
5 |
p. e213-e221
|
article
|
| 4 |
Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study
|
Goh, Zhong
|
|
|
23 |
5 |
p. 370-378
|
article
|
| 5 |
Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma
|
Mateos, María-Victoria
|
|
|
23 |
5 |
p. 385-393
|
article
|
| 6 |
Distinctive Attributes of Indian Patients With Classical BCR::ABL1 Negative Myeloproliferative Neoplasms: Unified Clinical and Laboratory Data
|
Singh, Suvir
|
|
|
23 |
5 |
p. 360-369.e1
|
article
|
| 7 |
Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community Setting
|
Gershon, Anda
|
|
|
23 |
5 |
p. e222-e231
|
article
|
| 8 |
Editorial Board
|
|
|
|
23 |
5 |
p. A1-A2
|
article
|
| 9 |
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium
|
Côté, Julie
|
|
|
23 |
5 |
p. 340-354
|
article
|
| 10 |
Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma
|
MacDougall, Kira
|
|
|
23 |
5 |
p. 379-384
|
article
|
| 11 |
Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review
|
Kaur, Jasneet
|
|
|
23 |
5 |
p. e195-e212
|
article
|
| 12 |
Patient Confidence and Information Preferences During the Treatment Decision-making Process: Results From a Large Multiple Myeloma Patient Survey Across 12 Countries in Europe and Israel
|
Mellqvist, Ulf-Henrik
|
|
|
23 |
5 |
p. e240-e251.e12
|
article
|
| 13 |
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes
|
Tinsley-Vance, Sara M
|
|
|
23 |
5 |
p. 355-359
|
article
|
| 14 |
SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It
|
Patel, Anand A.
|
|
|
23 |
5 |
p. 303-309
|
article
|
| 15 |
SOHO State-of-the-Art Updates and Next Questions | BCMA-Directed CAR T-Cells: Early Results and Future Directions
|
Biltibo, Eden
|
|
|
23 |
5 |
p. 310-321
|
article
|
| 16 |
SOHO State of the Art Updates and Next Questions | Infections in Chronic Lymphocytic Leukemia Patients: Risks and Management
|
Gargiulo, Ernesto
|
|
|
23 |
5 |
p. 322-332
|
article
|
| 17 |
SOHO State of the Art Updates and Next Questions | Update on Treatment-Free Remission in Chronic Myeloid Leukemia (CML)
|
Mikhaeel, Sherrie
|
|
|
23 |
5 |
p. 333-339
|
article
|
| 18 |
Table of Contents
|
|
|
|
23 |
5 |
p. A3-A5
|
article
|
Journal description